Clinical trial
Assessment of Endogenous Oxalate Synthesis
NCT05229952 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Endogenous Oxalate Synthesis
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2022
- Completion date
- September 9, 2024
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, kidney stone, obesity